Epetōme is a nutraceutical company focused on gut health, offering a synbiotic duo cap probiotic designed to deliver 50 billion CFU of 11 bacterial strains with FOS fibre, vitamin D3, zinc and biotin. The product uses a two-layer capsule technology to target delivery in the gut, marketed as a once-daily supplement developed by nutritionist Emily English. The company emphasizes evidence-based gut health concepts and provides a research library and expert insights, with operations and founder presence in the United Kingdom. The brand positions itself as a science-meets-simplicity approach to daily gut health with a strong emphasis on clinically-trialed strains and digestive well-being.
No recent news for this company.
No recent deals for this company.